D. Westaby

B7-H3 as a Therapeutic Target in Advanced Prostate Cancer.

C. Drake, N. Tunariu, M. Shen, 2022, European urology.

Optimising CT-guided biopsies of sclerotic bone lesions in cancer patients

D. Koh, N. Tunariu, M. Blackledge, 2022, European Radiology.

Upregulation of GALNT7 in prostate cancer modifies O-glycosylation and promotes tumour growth

L. Harries, C. Bertozzi, A. Freeman, 2023, Oncogene.

Liver,Biliary tract and pancreatic disease. Kumar,P.,Clarke.Eds

A. Burroughs, D. Westaby, 2005 .

Targeting the Intrinsic Apoptosis Pathway: A Window of Opportunity for Prostate Cancer

S. Balk, J. D. de Bono, A. Sharp, 2021, Cancers.

A New Old Target: Androgen Receptor Signaling and Advanced Prostate Cancer.

J. Welti, J. D. de Bono, A. Sharp, 2021, Annual review of pharmacology and toxicology.

Beyond the Androgen Receptor: The Sequence, the Mutants, and New Avengers in the Treatment of Castrate-Resistant Metastatic Prostate Cancer.

M. Fleming, A. Aparicio, J. D. de Bono, 2021, American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting.

Germline ATM Mutations Detected by Somatic DNA Sequencing in Lethal Prostate Cancer

B. Gurel, S. Miranda, J. Mateo, 2023, European urology open science.

Alcohol and the liver.

D. Westaby, K. Hills, 1997, British journal of hospital medicine.

Neonatal sclerosing cholangitis in two siblings: a category of progressive intrahepatic cholestasis.

B. Portmann, A. Mowat, J. Karani, 1993, Journal of pediatric gastroenterology and nutrition.

Targeting myeloid chemotaxis to reverse prostate cancer therapy resistance

N. Tunariu, A. Stathis, R. Ruddle, 2023, Nature.